Abeona Therapeutics trades on the NASDAQ under the ticker symbol ABEO at approximately $6.16 per share. Its daily valuation fluctuates within a 52-week range spanning from a low of roughly $4.00 to a high of $7.65, driven by clinical trial updates, regulatory developments, and broader micro-cap biotechnology market sentiment.